The financial opportunity associated with cell therapy manufacturing market has been analyzed across the following segments:
- Type of Cell Therapy
- T cell therapies
- Dendritic cell therapies
- NK cell therapies
- Stem cell therapies
- Source of Cell
- Autologous
- Allogeneic
- Scale of Operation
- Clinical
- Commercial
- Purpose of Manufacturing
- In-house Manufacturing
- Contract Manufacturing
- Geographical Regions
- North America
- Europe
- Asia Pacific
- Rest of the World
The Cell Therapy Manufacturing Market (5th Edition), 2022-2035 report features the following companies, which we identified to be key players in this domain:
- AGC Biologics
- BioNTech Innovative Manufacturing Services
- Cell and Gene Therapy Catapult
- Cell Therapies
- Center for Cell and Gene Therapy, Baylor College of Medicine
- Center for Cell Manufacturing Ireland, National University of Ireland
- Charles River Laboratories
- Clinical Cell and Vaccine Production Facility, University of Pennsylvania
- FUJIFILM Cellular Dynamics
- Guy’s and St. Thomas GMP Facility, Guy’s Hospital
- KBI Biopharma
- Laboratory for Cell and Gene Medicine, Stanford University
- Lonza
- MEDINET
- Minaris Regenerative Medicine
- Molecular and Cellular Therapeutics, University of Minnesota
- Newcastle Cellular Therapies Facility, Newcastle University
- Nikon CeLL innovation
- Rayne Cell Therapy Suite, King’s College London
- RoslinCT
- Scottish National Blood Transfusion Service, Scottish Centre of Regenerative Medicine
- Sydney Cell and Gene Therapy
- Thermofisher Scientific
- WuXi AppTec
Table of Contents
- Preface
2. Executive Summary
Introduction
- Market Overview
- Regulatory Landscape
- Roadmaps for Overcoming Challenges
- Automation Technologies for Cell Therapies Manufacturing
- Profiles: Industry Players
- Profiles: Non-Industry Players
- Role of Non-Profit Organizations
- Clinical Trial Analysis
- Partnerships and Collaborations
- Recent Expansions
- Big Pharma Initiatives
- Capacity Analysis
- Demand Analysis
- Cost Price Analysis
- Make Versus Buy Decision Making Framework
- Total Cost of Ownership
- Market Sizing and Opportunity Analysis
- Key Insights
- SWOT Analysis
- Concluding Remarks
- Survey Analysis
- Interview Transcripts
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html
Learn from experts: do you know about these emerging industry trends?
Deep Learning-based Interoperability: Advanced Neural Networks Mimicking the Human Brain
Novel Cell Cytometers: Need of the Hour
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
